EDAP TMS S.A.: EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology
EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored ...
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology
A (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Léon Bérard, Lyon, ...